Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Hypertension. 2018;71:530–7.

Article  PubMed  CAS  Google Scholar 

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, et al. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol. 2019;181:339–50.

Article  PubMed  CAS  Google Scholar 

Matsuda N, Yoshida Y, Inobe N, Yoshimura M, Iwamoto M, Nagai S, et al. Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2024, https://doi.org/10.1038/s41440-024-01997-w.

Levy DG, Rocha R, Funder JW. Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab. 2004;89:2736–40.

Article  PubMed  CAS  Google Scholar 

Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–17.

Article  PubMed  CAS  Google Scholar 

Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–21.

Article  PubMed  CAS  Google Scholar 

McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med. 2012;18:1429–33.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burniston JG, Saini A, Tan LB, Goldspink DF. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol. 2005;39:395–9.

Article  PubMed  CAS  Google Scholar 

Dogra P, Šambula L, Saini J, Thangamuthu K, Athimulam S, Delivanis DA, et al. High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment. Eur J Endocrinol. 2023;189:318–26.

Article  PubMed  PubMed Central  Google Scholar 

Park KS, Lee GY, Seo YM, Seo SH, Yoo JI. The relationship between extracellular water-to-body water ratio and sarcopenia according to the newly revised Asian Working Group for Sarcopenia: 2019 Consensus Update. Aging Clin Exp Res. 2021;33:2471–7.

Article  PubMed  Google Scholar